PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX:LCI) today said that the U.S. Food and Drug Administration (FDA) recently completed an inspection of two of the company’s manufacturing facilities, including quality systems. The two-year annual cGMP audit concluded with a total of four minor observations.
